Category:
Prophylactic Biological Products
CAS NO:
NA
Standard:
In-house Standards,
A fixed-dose combination of Abacavir, Dolutegravir, and Lamivudine is an antiretroviral therapy for HIV-1. It integrates nucleoside reverse transcriptase inhibitors with an integrase strand transfer inhibitor.
Screening for HLA-B*5701 allele is mandatory to prevent hypersensitivity. Store below 25°C in dry conditions. Contraindicated in patients with severe hepatic impairment or known hypersensitivity to components.